The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Eli Lilly & Co.

  • LLY
  • NYSE
  • Consumer Products
  • Latest 62.62
  • Currency US$
  • Change 0.16
  • Percent Change 0.256 %
  • Volume 2,748,642
  • Wed Jul 9, 2014 04:00 PM EDT NYSE data delayed 15 minutes.
  • Open 62.53
  • Previous Close 62.46
  • High 62.71
  • Low 62.27
  • Bidx0 59.80
  • Askx0 62.70
  • 52-week High06/30 63.38
  • 52-week Low10/09 47.53
  • Beta 0.412
  • Market Cap 70,119.37M
  • EPS 3.71
  • P/E 16.879
  • Forward P/E 19.94
  • PEG 4.93
  • Annual Dividend 1.96
  • Yield 3.13
Globe Investor - GIT Upsells
It's never been a better time to get Globe Unlimited
Try Globe Unlimited, featuring new Globe Investor Tools,
for a special trial rate. Only 99¢ for your first month.


Are you a Globe Investor Gold subscriber?
You qualify for complimentary access to Globe Unlimited.
Visit: globeandmail.com/globeplusunlimited
Try it today

News

Financials & Calendars

Income Statement

  • Sales $22,194,200,000
  • Earnings $3,864,700,000
  • Return on Equity 21.48%

Cash Flow

  • Cash Flow --
  • Cash $3,888,000,000
  • Current Ratio 1.97

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $34,756,900,000
  • Liabilities $16,408,200,000
  • Liabilities-to-Equity Ratio 0.89

Price Ratios

  • Price to Sales 3.16
  • Price to Book 3.82
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Apr 24 $0.70 Jul 24 $0.65
Surprises Jan 30 1.37% n/a n/a
Dividends May 13 $0.49 Aug 13 $0.49
Splits n/a -- n/a n/a

12 months ended Jul 10, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Related Securities
Symbol Type Latest % Chg

Officers

  • JOHN C. LECHLEITER, Ph.D. Chairman;President; C.E.O.& Di
  • DERICA W. RICE Exec.V.P. Global Services & C.
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

LILLY CORPORATE CTR DROP CODE
INDIANAPOLIS, IN
46285

Phone: (317)-276-2000
Fax: (317)-2766331

cardwell_leanna_k@lilly.com
www.lilly.com

Ideas & Discussion

Live Discussion of LLY on StockTwits